Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis

BACKGROUND: MELD score and MELD score derivates are used to objectify and grade the risk of liver-related death in patients with liver cirrhosis. We recently proposed a new predictive model that combines serum creatinine levels and maximum liver function capacity (LiMAx®), namely the CreLiMAx risk s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Gastroenterol
Autores principales: Dziodzio, Tomasz, Öllinger, Robert, Schöning, Wenzel, Rothkäppel, Antonia, Nikolov, Radoslav, Juraszek, Andrzej, Ritschl, Paul V., Stockmann, Martin, Pratschke, Johann, Jara, Maximilian
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425128/
https://ncbi.nlm.nih.gov/pubmed/32787947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01407-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares